Fulcrum Therapeutics Inc. – Filings and Transcripts

NASDAQ: FULC
Share price (9/23/26): $3.81
Market cap (9/23/26): $291 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Details of business combination or exchange offer

Business combination disclosure

Business combination disclosure

Business combination disclosure

Registration of securities for employees

Ownership Filter

Tourangeau Greg

Ra Capital Management, L.P.

TCG Crossover GP II, LLC

Nantahala Capital Management, LLC

Montanova Capital, LLC

News Filter

Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies

Change in Directors, Officers or Compensation

Shareholder Vote Results

Change in Directors, Officers or Compensation

Cost of Exit or Disposal Activities, Other Events

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission